ADAdaptimmune is a clinical-stage biopharmaceutical company focused on developing innovative therapies for solid tumors using engineered T-cell technologies.
Genmab A/S is an innovative biotechnology company focused on developing antibody therapeutics to improve patient care, particularly in oncology.
Replimune is focused on developing innovative oncolytic immunotherapies aimed at treating difficult-to-treat cancers by harnessing the immune system.
Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer.
LBLegend Biotech is a commercial-stage biotechnology firm specializing in the development of innovative therapies for cancer treatment.
Adaptive Biotechnologies is a commercial-stage biotechnology company that harnesses the adaptive immune system's biology to transform disease diagnosis and treatment, offering an immune-sequencing platform for research and clinical diagnostics.